Evaluation of Antimicrobial Treatments in Children with Acute Otitis Media in Spain: A Pharmacokinetic-Pharmacodynamic (PK/PD) Approach

References

• Solis G, Ochoa C, Perez Mendez C. The variability and appropriateness of the antibiotic prescription of acute otitis media in childhood. The Spanish Study Group for Antibiotic Treatments. Int J Pediatr Otorhinolaryngol 2000; 56: 175–84.
   PubMed Web of Science ®Google Scholar
• del Castillo F, Baquero-Artigao F, Garcia-Perea A. Influence of recent antibiotic therapy on antimicrobial resis-tance of Streptococcus pneumoniae in children with acute otitis media in Spain. Pediatr Infect Dis J 1998; 17: 94–7.
   PubMed Web of Science ®Google Scholar
• Drusano GL, Craig WA. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respi-ratory tract infections. J Chemother 1997; 9 Suppl 3: 38–44.
   PubMed Web of Science ®Google Scholar
• Canafax DM, Yuan Z, Chonmaitree T, Deka K, Russlie HQ, Giebink GS. Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media. Pediatr Infect Dis J 1998; 17: 149–56.
   PubMed Web of Science ®Google Scholar
• Thoroddsen E, Marr C, Efthymiopoulos C, Thorarinsson H. Concentration of cefuroxime in middle ear effusion of chil-dren with acute otitis media. Pediatr Infect Dis J 1997; 16, 959–962.
   PubMed Web of Science ®Google Scholar
• Gudnason T, Gudbrandsson F, Barsanti F, Kristinsson KG. Penetration of ceftriaxone into the middle ear fluid of children. Pediatr Infect Dis J 1998; 17: 258–60.
   PubMed Web of Science ®Google Scholar
• Craig WA, Andes D. Pharmacokinetics and pharmacody-namics of antibiotics in otitis media. Pediatr Infect Dis J 1996; 15: 255–9.
   PubMed Web of Science ®Google Scholar
• Harrison CJ. Using antibiotic concentrations in middle ear fluid to predict potential clinical efficacy. Pediatr Infect Dis J 1997; 16: S12–6.
   PubMed Web of Science ®Google Scholar
• Blumer JL. Fundamental basis for rational therapeutics in acute otitis media. Pediatr Infect Dis J 1999; 18: 1130–40.
   PubMed Web of Science ®Google Scholar
• Scaglione F, Caronzolo D, Pintucci JP, Fraschini F. Measurement of cefaclor and amoxicillin-clavulanic acid levels in middle-ear fluid in patients with acute otitis media. Antimicrob Agents Chemother 2003; 47: 2987–9.
   PubMed Web of Science ®Google Scholar
• Sundberg L, Eden T. Penetration of enoxacin into mid-dle ear effusion. Acta Otolaryngol 1990; 109: 438–43.
   PubMed Web of Science ®Google Scholar
• Eden T. Long-standing otitis media with effusion-a convenient model for the study of antibiotic penetration to res-piratory tract secretions. Scand J Infect Dis Suppl 1985; 44: 46–51.
   PubMedGoogle Scholar
• Shyu WC, Haddad J, Reilly J, et al. Penetration of cef-prozil into middle ear fluid of patients with otitis media. Antimicrob Agents Chemother 1994; 38: 2210–2.
   PubMed Web of Science ®Google Scholar
• Isla A, Canut A, Gascem AR, et al. Pharmacokinetic/ pharmacodynamic evaluation of antimicrobial treatments of orofacial odontogenic infections. Clin Pharmacokinet 2005; 44: 305–16.
   PubMed Web of Science ®Google Scholar
• Schaad UB, Casey PA, Ravenscroft AT. Pharmacokinetics of a syrup formulation of amoxycillin-potas-sium clavulanate in children. J Antimicrob Chemother 1986; 17: 341–5.
   PubMed Web of Science ®Google Scholar
• Ginsburg CM, McCracken GH, Jr., Thomas ML, Clahsen J. Comparative pharmacokinetics of amoxicillin and ampicillin in infants and children. Pediatrics 1979; 64: 627–31.
   PubMed Web of Science ®Google Scholar
• Scott II, Ormrod D, Goa KL. Cefuroxime axetil: an updated review of its use in the management of bacterial infections. Drugs 2001; 61: 1455–500.
   PubMed Web of Science ®Google Scholar
• Taylor CJ, Johnson TN. Cefuroxime axetil pediatric suspension: a pharmacokinetic evaluation. Research Clin Forums 1990; 12: 31–36.
   Google Scholar
• Rocephin. (ceftriaxone) package insert. Nutley, New Jersey: Roche Pharmaceuticals, 2000.
   Google Scholar
• Perez-Trallero E, Fernandez-Mazarrasa C, Garcia-Rey C, Souza E, Aguilar L, Garcia-de-Lomas J, Baquero F; Spanish Surveillance Group for Respiratory Pathogens. Antimicrobial susceptibilities of 1,684 Streptococcus pneumo-niae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multi-center surveillance study in Spain. Antimicrob Agents Chemother 2001; 45: 3334–40.
   Google Scholar
• Marco F, Garcia-de-Lomas J, Garcia-Rey C, Souza E, Aguilar L, Fernandez-Mazarrasa C. Antimicrobial susceptibili-ties of 1,730 Haemophilus influenzae respiratory tract iso-lates in Spain in 1998-1999. Antimicrob Agents Chemother 2001; 45: 3226–8.
   PubMed Web of Science ®Google Scholar
• Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003; 52: 229–46.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacte-ria that grow aerobically, 6th edition. Approved standard M7-A6. NCCLS, Wayne, Pa. USA., 2003.
   Google Scholar
• Jacobs MR. How can we predict bacterial eradication? Int J Infect Dis 2003; 7 (Suppl 1): S13–20.
   PubMedGoogle Scholar
• Woodnutt G, Berry V. Efficacy of high-dose amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae. Antimicrob Agents Chemother 1999; 43: 35–40.
   PubMed Web of Science ®Google Scholar
• Bowker KE, Noel AR, MacGowan AP. The magnitude of the pharmacodynamic index which determines outcome with amoxicillin/clavulanate is similar for Streptococcus pneu-moniae and Haemophilus influenzae and not dependant on inoculum., 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2003. Vol. Abstract A1158.
   Google Scholar
• Craig WA. Antimicrobial resistance issues of the future. Diag Microbiol Infect Dis 1996; 25, 213–217.
   PubMed Web of Science ®Google Scholar
• Perez-Trallero E, Marimon JM, Gonzalez A, Garcia-Rey C, Aguilar L. Genetic relatedness of recently collected Spanish respiratory tract Streptococcus pneumoniae isolates with reduced susceptibility to amoxicillin. Antimicrob Agents Chemother 2003; 47: 3637–9.
   PubMed Web of Science ®Google Scholar
• White AR, Kaye C, Poupard J, Pypstra R, Woodnutt G, Wynne B. Augmentin (amoxicillin/clavulanate) in the treat-ment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimi-crobial agent. J Antimicrob Chemother 2004; 53 Suppl 1: i3–20.
   PubMed Web of Science ®Google Scholar
• Casal J, Gimenez MJ, Aguilar L, et al. Beta-lactam activity against resistant pneumococcal strains is enhanced by the immune system. J Antimicrob Chemother 2002; 50 (Suppl S2) :83–6.
   PubMed Web of Science ®Google Scholar
• Aguilar L, Gimenez MJ, Garcia-Rey C, Martin JE. New strategies to overcome antimicrobial resistance in Streptococcus pneumoniae with beta-lactam antibiotics. J Antimicrob Chemother 2002; 50 (Suppl 52):93–100.
   PubMed Web of Science ®Google Scholar
• Leibovitz E, Piglansky L, Raiz S, Press J, Leiberman A, Dagan R. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonre-sponsive acute otitis media in children. Pediatr Infect Dis J 2000; 19: 1040–5.
   Google Scholar
• Dagan R. Treatment of acute otitis media - challenges in the era of antibiotic resistance. Vaccine 2000; 19 (Suppl 1): S9–S16.
   PubMed Web of Science ®Google Scholar
• Dagan R, Johnson CE, McLinn S, et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J 2000; 19: 95–104.
   PubMed Web of Science ®Google Scholar
• Dagan R, Hoberman A, Johnson C, et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J 2001; 20: 829–37.
   PubMed Web of Science ®Google Scholar
• Scaglione F. Predicting the clinical efficacy of antibi-otics: toward definitive criteria. Curr Therapeutic Res 1997; 16 (Suppl.3): 56-59.
   Google Scholar
• Sundberg L, Cederberg A. Penetration of clar-ithromycin and its 14-hydroxy metabolite into middle ear effu-sion in children with secretory otitis media. J Antimicrob Chemother 1994; 33, 299–307.
   PubMed Web of Science ®Google Scholar
• Can VN, Chu SY, Kusmiesz H, Craft JC. Pharmaco-kinetics of a clarithromycin suspension in infants and children. AntimicrobAgents Chemother 1992; 36: 2478–2480.
   PubMed Web of Science ®Google Scholar
• Guay DRP, Craft JC. Overview of the pharmacology of clarithromycin suspension in children and a comparison with that in adults. Pediatr Infect Dis J 1993; 12, 106–111.
   PubMed Web of Science ®Google Scholar
• http:www.fda.gov/ohrms/dockets/ac/01/briefing/3802b1_01_pfizer.pdf
   Google Scholar
• Pukander J, Rautianen M. Penetration of azithromycin into middle ear effusions in acute and secretory otitis media in children. J Antimicrob Chemother 1996; 37, (Suppl. C): 53-61.
   Google Scholar
• Dagan R, Leibovitz E, Hiss DM, Leiberman I, Jacobs MR, Craig W, Yagupsky P. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother 2000; 44, 43–50.
   PubMed Web of Science ®Google Scholar
• Rothermel CD. Single-dose azithromycin for acute otitis media: a pharmacokinetic/pharmacodynamic rationale. Curr Ther Res 2003; 65: 4–15.
   Google Scholar
• Arguedas A, Loaiza C, Perez A, Gutierrez A, Herrera ML, Rothermel CD. A pilot study of single-dose azithromycin versus three-day azithromycin or single-dose ceftriaxone for uncomplicated acute otitis media in children. Curr Ther Res 2003; 64:A16–A29.
   Web of Science ®Google Scholar
• Arrieta A, Arguedas A, Fernandez P, et al. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treat-ment of children with recurrent or persistent acute otitis media. Antimicrob Agents Chemother 2003; 47: 3179–86.
   PubMed Web of Science ®Google Scholar
• Lonks JR, Garau J, Medeiros AA. Implications of antimicrobial resistance in the empirical treatment of commu-nity-acquired respiratory tract infections: the case of macrolides. J Antimicrob Chemother 2002; 50 (Suppl 52):87–92.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO report on infectious diseases. Overcoming antimicrobial resistance. WHO, Geneva, Switzerland, 2000.
   Google Scholar
• World Health Organization. WHO model prescribing information, drugs used in bacterial infections. WHO, Geneva, Switzerland, 2001.
   Google Scholar